Modified BEAM as a conditioning regimen for mantle cell lymphoma patients undergoing autologous hematopoietic stem cell transplantation

IF 3.1 3区医学 Q2 HEMATOLOGY Therapeutic Advances in Hematology Pub Date : 2024-05-17 DOI:10.1177/20406207241251541

Piero Galieni, Sadia Falcioni, Emanuela Troiani, Paola Picardi, Catia Bigazzi, Denise Maravalle, Federica De Giorgi, Roberta Taborro, Stefano Angelini

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

将改良 BEAM 作为接受自体造血干细胞移植的套细胞淋巴瘤患者的调理方案

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Therapeutic Advances in Hematology HEMATOLOGY-

CiteScore

4.30

自引率

0.00%

发文量

审稿时长

7 weeks

期刊介绍： Therapeutic Advances in Hematology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of hematology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in hematology, providing a forum in print and online for publishing the highest quality articles in this area.

期刊最新文献

Clinical practice of the endothelial activation and stress index and its modified versions in multiple myeloma and the effects on prognosis. Efficacy and safety of chimeric antigen receptor T-cell therapy in relapsed/refractory large B-cell lymphoma: a systematic review and meta-analysis. Efficacy and safety of avatrombopag in aplastic anemia: a comprehensive review of clinical evidence. Mogamulizumab plus etoposide in the management of mycosis fungoides with blood involvement: a case report. Ibrutinib oral suspension bioavailability and compatibility for optimal enteral administration route.